| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |